These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9377349)

  • 1. [The efficacy of proton-pump inhibitors in the treatment of acid-dependent diseases].
    Tkach SM
    Lik Sprava; 1997; (3):30-5. PubMed ID: 9377349
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of Helicobacter pylori infection. Treatment of ulcers can be improved and over-reliance on proton pump inhibitors reduced.
    Beales IL; Parsons HK; Sanders DS; Carter MJ; Lobo AJ; Watts T
    BMJ; 2002 Mar; 324(7337):614. PubMed ID: 11884340
    [No Abstract]   [Full Text] [Related]  

  • 3. Quadruple treatments for Helicobacter pylori.
    Mascitelli L; Pezzetta F
    Lancet; 2003 Jan; 361(9351):86. PubMed ID: 12517510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gastroduodenal ulcer disease: therapeutic possibilities].
    Inauen W
    Praxis (Bern 1994); 1995 May; 84(20):585-9. PubMed ID: 7761731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
    Zakharova NV
    Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 9. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of clarithromycin in eradicating Helicobacter pylori.
    Satoh K; Kimura K; Takimoto T; Kihira K; Taniguchi Y; Saifuku K
    J Gastroenterol; 1996 Nov; 31 Suppl 9():53-5. PubMed ID: 8959520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leaving Helicobacter pylori no chance. Triple therapy should consider resistance status].
    MMW Fortschr Med; 2005 May; 147(20):52. PubMed ID: 15957863
    [No Abstract]   [Full Text] [Related]  

  • 12. [History of the treatment of Helicobacter pylori and clinical efficacy].
    Yamamoto I; Fukuda Y; Shimoyama T
    Nihon Rinsho; 1999 Jan; 57(1):32-42. PubMed ID: 10036933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA
    Eksp Klin Gastroenterol; 2004; (3):40-4. PubMed ID: 15560400
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment characteristics of patients with peptic ulcer infected with Helicobacter pylori].
    Kharchenko NV
    Lik Sprava; 1999 Mar; (2):70-4. PubMed ID: 10424047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice guidelines for treatment of peptic ulcer disease.
    Fennerty MB
    JAMA; 1996 Oct; 276(14):1135; author reply 1136-7. PubMed ID: 8827957
    [No Abstract]   [Full Text] [Related]  

  • 16. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
    Hunt RH
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):36S-40S; discussion 40S-43S. PubMed ID: 9127625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proton pump blockade and Helicobacter pylori: status of current knowledge and clinical importance].
    Labenz J; Börsch G
    Leber Magen Darm; 1992 Sep; 22(5):169-72. PubMed ID: 1406011
    [No Abstract]   [Full Text] [Related]  

  • 19. Proton pump inhibitors and acid-related diseases.
    Sachs G
    Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)].
    Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():627-31. PubMed ID: 11979859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.